Stock
Apellis Pharmaceuticals Inc
Ticker not mapped · held by 7 managers
Reported value
$99.3M
Holders
7
+1 new · −2 exited
Holders’ est. mark
$2.63M
Price effect on 6 books still in the name
Largest holder
$47.2M
DeepCurrents Investment Group LLC
Holder count by quarter
Who holds it
Notable only| Investor | Shares | Value | Est. mark | Change |
|---|---|---|---|---|
| DeepCurrents Investment Group LLC | 44.5M | $47.2M | $1.26M | Added$1.58M |
| Linden Advisors LP | 28.1M | $29.6M | $535.3K | Added$535.3K |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 11.9M | $12.7M | $612.5K | Added$612.5K |
| D. E. Shaw & Co., Inc. | 5M | $5.3M | $139.6K | Added$139.6K |
| WOLVERINE ASSET MANAGEMENT LLC | 3.12M | $3.31M | $83.4K | Added$83.4K |
| CANTOR FITZGERALD, L. P. | 1.13M | $1.2M | — | New |
| CITIGROUP INC | 6K | $6.3K | $139 | Added$139 |
Who left
Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.